For the first time, a targeted gene replacement therapy has been approved in Canada, bringing hope to thousands of people struggling with a genetic condition in which their sight slowly degrades.
For the first time, a targeted gene replacement therapy has been approved in Canada, bringing hope to thousands of people struggling with a genetic condition in which their sight slowly degrades.
Comments are closed.